Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
181
天
Class I capsid assembly modulators induce potent anti-HBV activity through direct viral suppression, innate immune activation and caspase-3-independent clearance of infected hepatocytes
作者
Pu Wang; Xinchang Liu; Yong Xie; Yingjun Zhang; Baohua Gu; Jing Li; Yunfu Chen展开收起
作者单位
Sunshine Lake Pharma Co., Ltd., Dongguan, PR China; State Key Laboratory of Anti-Infective Drug Discovery and Development, Dongguan, PR China; Enterprise Key Laboratory of Anti-viral Drug Development for Guangdong Province, Dongguan, PR China展开收起
74
天
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing
作者
Hiteshi Vaidya; Manoj Kumar展开收起
作者单位
Virology Unit, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39A, Chandigarh, 160036, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India; Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research (NIPER), Sahibzada Ajit Singh Nagar, Punjab, 160062, India展开收起
115
天
Dual-targeting engineered binding proteins block SARS-CoV-2 infection and complement activation
作者
Fan Pu; Yiwan Guo; Xinni Pan; Xin Liu; Fan Yang展开收起
作者单位
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue #1277, Wuhan, 430022, China; Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine, Wuhan, 430022, China; Hubei Key Laboratory of Molecular Imaging, Wuhan, 430022, China; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University, Wuhan, China展开收起
110
天
HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearance
作者
Bai-Hua Zhang; Yuanping Zhou; Yukun Wu; Stephen Horrigan; Laura Luckenbaugh; Jianming Hu; Fabien Zoulim; Yong-Yuan Zhang展开收起
作者单位
Virology, HBVtech, Rockville, MD, USA; Department of Infectious Diseases & Gastroenterology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China; The YW Statistical Consulting, Ellicott City, MD, USA; Preclinical Department, Noble Life Sciences, Sykesville, MD, USA; Department of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA, USA; UMR PaThLiv U1350, INSERM, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Lyon Hepatology Institute, IHU EVEREST, Lyon, France展开收起
137
天
Oligomerized receptor binding domain blocks pan-sarbecovirus infection via enhanced avidity to host receptor
作者
Jintao Zou; Lingyu Su; Jiansheng Lu; Haiming Jing; Jiahang Liu; Xiaoqiang Zeng; Menghan Ma; De Zhao; Jun Zhang; Zhang Zhang; Jinyong Zhang; Xiaopeng Zhang展开收起
作者单位
National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, Beijing, 100071, China; Nanhu Laboratory, Jiaxing, Zhejiang, 314050, China; National Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Army Medical University, Chongqing, 400038, China展开收起
26
天
Antiviral profile of hepatitis B virus capsid assembly modulator ALG-001075, the parent of pevifoscorvir sodium
作者
Yannick Debing; Hannah Vanrusselt; Cheng Liu; Jordi Verheyen; Lars Degrauwe; Dieudonné Buh Kum; Abel Acosta Sanchez; Adilson Carlos Francisco; Emma Wanicek; Hans J. Netter; Paul A. Ramsland; Andrew Leis; Shabih Shakeel; Jerome Deval; Michael Welch; Vladimir Serebryany; Antitsa Stoycheva; Leonid Beigelman; Pierre Raboisson; Sandrine Vendeville; Tse-I Lin; Lawrence M. Blatt; David B. Smith; Julian A. Symons; Lauriane Lecoq; Andreas Jekle展开收起
作者单位
Aligos Belgium BV, Leuven, Belgium; Aligos Therapeutics, Inc., South San Francisco, United States; Novalix, Leuven, Belgium; Molecular Microbiology and Structural Biochemistry (MMSB), UMR 5086 CNRS, Université de Lyon, France; School of Science, STEM College, RMIT University, Bundoora, Victoria, Australia; Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia; The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Melbourne, VIC, 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3052, Australia; ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Bio21 Molecular Science and 9 Biotechnology Institute, The University of Melbourne, Parkville, Melbourne, VIC, 3052, Australia展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天